346 related articles for article (PubMed ID: 23429089)
1. Composition of hemagglutinin and neuraminidase affects the antigen yield of influenza A(H1N1)pdm09 candidate vaccine viruses.
Shirakura M; Kawaguchi A; Tashiro M; Nobusawa E
Jpn J Infect Dis; 2013; 66(1):65-8. PubMed ID: 23429089
[TBL] [Abstract][Full Text] [Related]
2. Optimization of influenza A vaccine virus by reverse genetic using chimeric HA and NA genes with an extended PR8 backbone.
Medina J; Boukhebza H; De Saint Jean A; Sodoyer R; Legastelois I; Moste C
Vaccine; 2015 Aug; 33(35):4221-7. PubMed ID: 26206270
[TBL] [Abstract][Full Text] [Related]
3. Construction and comparison of different source neuraminidase candidate vaccine strains for human infection with Eurasian avian-like influenza H1N1 virus.
Liu L; Lu J; Zhou J; Li Z; Zhang H; Wang D; Shu Y
Microbes Infect; 2017 Dec; 19(12):635-640. PubMed ID: 28859895
[TBL] [Abstract][Full Text] [Related]
4. Segment 2 from influenza A(H1N1) 2009 pandemic viruses confers temperature-sensitive haemagglutinin yield on candidate vaccine virus growth in eggs that can be epistatically complemented by PB2 701D.
Hussain S; Turnbull ML; Pinto RM; McCauley JW; Engelhardt OG; Digard P
J Gen Virol; 2019 Jul; 100(7):1079-1092. PubMed ID: 31169484
[TBL] [Abstract][Full Text] [Related]
5. [High-yield reassortant virus containing hemagglutinin and neuraminidase genes of pandemic influenza A/Moscowl/01/2009 (H1N1) virus].
Ignat'eva AV; Rudneva IA; Timofeeva TA; Shilov AA; Zaberezhnyĭ AD; Aliper TI; Kaverin NV; L'vov DK
Vopr Virusol; 2011; 56(4):9-14. PubMed ID: 21899062
[TBL] [Abstract][Full Text] [Related]
6. Improved antigen yield in pandemic H1N1 (2009) candidate vaccine viruses with chimeric hemagglutinin molecules.
Harvey R; Guilfoyle KA; Roseby S; Robertson JS; Engelhardt OG
J Virol; 2011 Jun; 85(12):6086-90. PubMed ID: 21490098
[TBL] [Abstract][Full Text] [Related]
7. Generation of a Genetically Stable High-Fidelity Influenza Vaccine Strain.
Naito T; Mori K; Ushirogawa H; Takizawa N; Nobusawa E; Odagiri T; Tashiro M; Ohniwa RL; Nagata K; Saito M
J Virol; 2017 Mar; 91(6):. PubMed ID: 28053101
[TBL] [Abstract][Full Text] [Related]
8. Improvement of influenza vaccine strain A/Vietnam/1194/2004 (H5N1) growth with the neuraminidase packaging sequence from A/Puerto Rico/8/34.
Pan W; Dong Z; Meng W; Zhang W; Li T; Li C; Zhang B; Chen L
Hum Vaccin Immunother; 2012 Feb; 8(2):252-9. PubMed ID: 22426370
[TBL] [Abstract][Full Text] [Related]
9. Increased hemagglutinin content in a reassortant 2009 pandemic H1N1 influenza virus with chimeric neuraminidase containing donor A/Puerto Rico/8/34 virus transmembrane and stalk domains.
Jing X; Phy K; Li X; Ye Z
Vaccine; 2012 Jun; 30(28):4144-52. PubMed ID: 22561313
[TBL] [Abstract][Full Text] [Related]
10. Development of a high-yield reassortant influenza vaccine virus derived from the A/Anhui/1/2013 (H7N9) strain.
Nakamura K; Shirakura M; Suzuki Y; Naito T; Fujisaki S; Tashiro M; Nobusawa E
Vaccine; 2016 Jan; 34(3):328-33. PubMed ID: 26657023
[TBL] [Abstract][Full Text] [Related]
11. Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies.
Gao J; Couzens L; Burke DF; Wan H; Wilson P; Memoli MJ; Xu X; Harvey R; Wrammert J; Ahmed R; Taubenberger JK; Smith DJ; Fouchier RAM; Eichelberger MC
mBio; 2019 Apr; 10(2):. PubMed ID: 30967460
[TBL] [Abstract][Full Text] [Related]
12. Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.
Suzuki Y; Odagiri T; Tashiro M; Nobusawa E
PLoS One; 2016; 11(7):e0160040. PubMed ID: 27454606
[TBL] [Abstract][Full Text] [Related]
13. Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses.
Carter DM; Darby CA; Johnson SK; Carlock MA; Kirchenbaum GA; Allen JD; Vogel TU; Delagrave S; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978709
[TBL] [Abstract][Full Text] [Related]
14. Use of lentiviral pseudotypes as an alternative to reassortant or Triton X-100-treated wild-type Influenza viruses in the neuraminidase inhibition enzyme-linked lectin assay.
Biuso F; Palladino L; Manenti A; Stanzani V; Lapini G; Gao J; Couzens L; Eichelberger MC; Montomoli E
Influenza Other Respir Viruses; 2019 Sep; 13(5):504-516. PubMed ID: 31411006
[TBL] [Abstract][Full Text] [Related]
15. Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs.
Johnson A; Chen LM; Winne E; Santana W; Metcalfe MG; Mateu-Petit G; Ridenour C; Hossain MJ; Villanueva J; Zaki SR; Williams TL; Cox NJ; Barr JR; Donis RO
PLoS One; 2015; 10(6):e0128982. PubMed ID: 26068666
[TBL] [Abstract][Full Text] [Related]
16. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
17. [Formation of antibodies against neuraminidase of A/California/07/2009 (H1N1) influenza virus after immunization with live monovalent influenza vaccine].
Smolonogina TA; Desheva IuA; Shaldzhian AA; Grudinin MP; Rudenko LG
Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):72-6. PubMed ID: 22308734
[TBL] [Abstract][Full Text] [Related]
18. The M segment of the 2009 pandemic influenza virus confers increased neuraminidase activity, filamentous morphology, and efficient contact transmissibility to A/Puerto Rico/8/1934-based reassortant viruses.
Campbell PJ; Danzy S; Kyriakis CS; Deymier MJ; Lowen AC; Steel J
J Virol; 2014 Apr; 88(7):3802-14. PubMed ID: 24429367
[TBL] [Abstract][Full Text] [Related]
19. Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets.
Chen Z; Baz M; Lu J; Paskel M; Santos C; Subbarao K; Jin H; Matsuoka Y
J Virol; 2014 Jun; 88(12):7016-23. PubMed ID: 24719414
[TBL] [Abstract][Full Text] [Related]
20. Antigenicity of the 2015-2016 seasonal H1N1 human influenza virus HA and NA proteins.
Clark AM; DeDiego ML; Anderson CS; Wang J; Yang H; Nogales A; Martinez-Sobrido L; Zand MS; Sangster MY; Topham DJ
PLoS One; 2017; 12(11):e0188267. PubMed ID: 29145498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
